Dynamic PET denoising with HYPR processing

Journal of Nuclear Medicine

Volumn 51, Issue 7, 2010, Pages 1147-1154

  Christian, Bradley T ^a   Vandehey, Nicholas T ^a   Floberg, John M ^a   Mistretta, Charles A ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Denoising; Dynamic positron emission tomography; Instrumentation; Molecular imaging; Parametric images; PET

Indexed keywords

TRACER; BENZAMIDE DERIVATIVE; DIAGNOSTIC AGENT; N ((1 ALLYL 2 PYRROLIDINYL)METHYL) 5 (3 FLUOROPROPYL) 2,3 DIMETHOXYBENZAMIDE; N-((1-ALLYL-2-PYRROLIDINYL)METHYL)-5-(3-FLUOROPROPYL)-2,3-DIMETHOXYBENZAMIDE; OXYGEN; PYRROLIDINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ALGORITHM; ARTICLE; HIGHLY CONSTRAINED BACK PROJECTION; HUMAN; IMAGE PROCESSING; MOLECULAR IMAGING; NEUROIMAGING; NONHUMAN; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SIGNAL NOISE RATIO; TIME SERIES ANALYSIS; ANIMAL; BRAIN; COMPUTER SIMULATION; FACTUAL DATABASE; IMAGE QUALITY; MACACA; METHODOLOGY; SCINTISCANNING; STATISTICS;

ALGORITHMS; ANIMALS; BENZAMIDES; BRAIN; COMPUTER SIMULATION; DATABASES, FACTUAL; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MACACA MULATTA; OXYGEN RADIOISOTOPES; PHANTOMS, IMAGING; POSITRON-EMISSION TOMOGRAPHY; PYRROLIDINES; RADIOPHARMACEUTICALS;

EID: 77954979982     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.073999     Document Type: Article

References (37)

1. Phelps ME. Positron computed tomography studies of cerebral glucose metabolism in man: theory and application in nuclear medicine. Semin Nucl Med. 1981;11:32-49.
2. Di Chiro G, Brooks RA. PET quantitation: blessing and curse. J Nucl Med. 1988;29:1603-1604.
3. Keyes JW. SUV: standard uptake or silly useless value. J Nucl Med. 1995;36:1836-1839.
4. Hamberg LM, Hunter GJ, Alpert NM, Choi NC, Babich JW, Fischman AJ. The dose uptake ratio as an index of glucose-metabolism: useful parameter or oversimplification. J Nucl Med. 1994;35:1308-1312.
5. Huang SC. Anatomy of SUV. Nucl Med Biol. 2000;27:643-646.
6. Young H, Baum R, Cremerius U, et al. Measurement of clinical and subclinical tumour response using [F-18]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. Eur J Cancer. 1999;35:1773-1782.
7. Carson RE, Lange K. A statistical model for positron emission tomography: the EM parametric image reconstruction algorithm-comment. J Am Stat Assoc. 1985;80:20-22.
8. Snyder DL. Parameter estimation for dynamic studies in emission-tomography systems having list-mode data. IEEE Trans Nucl Sci. 1984;31:925-931.
9. Ollinger JM. Estimation algorithms for dynamic tracer studies using positronemission tomography. IEEE Trans Med Imaging. 1987;6:115-125.
10. Kao CM, Yap JT, Mukherjee J, Wernick MN. Image reconstruction for dynamic PET based on low-order approximation and restoration of the sinogram. IEEE Trans Med Imaging. 1997;16:738-749.
11. Wernick MN, Infusino EJ, Milosevic M. Fast spatio-temporal image reconstruction for dynamic PET. IEEE Trans Med Imaging. 1999;18:185-195.
12. Millet P, Ibanez V, Delforge J, Pappata S, Guimon J. Wavelet analysis of dynamic PET data: application to the parametric imaging of benzodiazepine receptor concentration. Neuroimage. 2000;11:458-472.
13. Turkheimer FE, Banati RB, Visvikis D, Aston JAD, Gunn RN, Cunningham VJ. Modeling dynamic PET-SPECT studies in the wavelet domain. J Cereb Blood Flow Metab. 2000;20:879-893.
14. Cselenyi Z, Olsson H, Farde L, Gulyas B. Wavelet-aided parametric mapping of cerebral dopamine D-2 receptors using the high affinity PET radioligand [C-11]FLB 457. Neuroimage. 2002;17:47-60.
15. Alpert NM, Reilhac A, Chio TC, Selesnick I. Optimization of dynamic measurement of receptor kinetics by wavelet denoising. Neuroimage. 2006;30:444-451.
16. Zhou Y, Huang SC, Bergsneider M, Wong DF. Improved parametric image generation using spatial-temporal analysis of dynamic PET studies. Neuroimage. 2002;15:697-707.
17. Mistretta CA, Wieben O, Velikina J, et al. Highly constrained backprojection for time-resolved MRI. Magn Reson Med. 2006;55:30-40.
18. Johnson KM, Velikina J, Wu Y, Kecskemeti S, Wieben O, Mistretta CA. Improved waveform fidelity using local HYPR reconstruction (HYPR LR). Magn Reson Med. 2008;59:456-462.
19. Boussion N, Hatt M, Lamare F, et al. A multiresolution image based approach for correction of partial volume effects in emission tomography. Phys Med Biol. 2006;51:1857-1876.
20. Tai C, Chatziioannou A, Siegel S, et al. Performance evaluation of the microPET P4: a PET system dedicated to animal imaging. Phys Med Biol. 2001;46:1845-1862. (Pubitemid 32677543)
21. Tai YC, Ruangma A, Rowland D, et al. Performance evaluation of the microPET Focus: a third-generation microPET scanner dedicated to animal imaging. J Nucl Med. 2005;46:455-463.
22. Avila-Rodriguez MA. Low Energy Cyclotron Production of Multivalent Transition Metals for PET Imaging and Therapy. Madison, WI: Medical Physics, University of Wisconsin-Madison; 2007.
23. Christian BT, Narayanan T, Shi B, Morris ED, Mantil J, Mukherjee J. Measuring the in vivo binding parameters of [F-18]-fallypride in monkeys using a PET multiple-injection protocol. J Cereb Blood Flow Metab. 2004;24:309-322.
24. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16:834-840.
25. Carson RE. PET parameter estimation using linear regression methods: bias and variability considerations. In: Uemura K, Lassen NA, Jones T, Kanno I, eds. Quantification of Brain Function: Tracer Kinetics and Image Analysis in Brain PET. Amsterdam, The Netherlands: Elsevier; 1993:499-507.
26. Hsu B, Alpert NM, Christian BT, Bonab AA, Morris ED, Fischman AJ. Noise properties of a graphical assay of receptor binding [abstract]. J Nucl Med. 1997;38:204P.
27. Slifstein M, Laruelle M. Effects of statistical noise on graphic analysis of PET neuroreceptor studies. J Nucl Med. 2000;41:2083-2088.
28. Logan J, Fowler JS, Volkow ND, Ding YS, Wang GJ, Alexoff DL. A strategy for removing the bias in the graphical analysis method. J Cereb Blood Flow Metab. 2001;21:307-320.
29. Price JC, Klunk WE, Lopresti BJ, et al. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh compound-B. J Cereb Blood Flow Metab. 2005;25:1528-1547.
30. Derdeyn CP, Videen TO, Simmons NR, et al. Count-based PET method for predicting ischemic stroke in patients with symptomatic carotid arterial occlusion. Radiology. 1999;212:499-506.
31. Parsey RV, Belanger MJ, Sullivan GM, et al. Biodistribution and radiation dosimetry of C-11-WAY100, 635 in humans. J Nucl Med. 2005;46:614-619.
32. Aston JAD, Gunn RN, Worsley KJ, Ma Y, Evans AC, Dagher A. A statistical method for the analysis of positron emission tomography neuroreceptor ligand data. Neuroimage. 2000;12:245-256.
33. Friston KJ, Malizia AL, Wilson S, Cunningham VJ, Jones T, Nutt DJ. Analysis of dynamic radioligand displacement or "activation" studies. J Cereb Blood Flow Metab. 1997;17:80-93.
34. Pappata S, Dehaene S, Poline JB, et al. In vivo detection of striatal dopamine release during reward: a PET study with C-11 raclopride and a single dynamic scan approach. Neuroimage. 2002;16:1015-1027.
35. Alpert NM, Badgaiyan RD, Livni E, Fischman AJ. A novel method for noninvasive detection of neuromodulatory changes in specific neurotransmitter systems. Neuroimage. 2003;19:1049-1060.
36. Christian BT, Lehrer DS, Shi BZ, et al. Measuring dopamine neuromodulation in the thalamus: using F-18 fallypride PET to study dopamine release during a spatial attention task. Neuroimage. 2006;31:139-152.
37. Normandin MD, Morris ED. Estimating neurotransmitter kinetics with ntPET: a simulation study of temporal precision and effects of biased data. Neuroimage. 2008;39:1162-1179.